Novo Nordisk to slash its insulin prices in the US

Move by Danish pharma giant comes in the wake of lawsuit in California and at the urging of President Biden

Novo Nordisk made an inauspicious start to 2023 in the US when it was among six firms sued by the state of California for driving up the cost of insulin.

That seems to have spurred the Danish pharma company into action, and it was announced this week that it intends to drastically cut the cost of its insulin medication products by the start of 2024.

“We have been working to develop a sustainable path forward that balances patient affordability, market dynamics and evolving policy changes,” said Steve Albers, the senior vice president of market access & public affairs at Novo Nordisk.

“Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulin – a responsibility we take seriously.” 

READ ALSO: California suing Novo Nordisk for “driving up the cost” of insulin

Pressure from the Prez
Novo Nordisk said it would slash the price of its insulin products – including the likes of Levemir, Novolin and NovoLog – by up to 75 percent.

The issue of pharma companies overcharging for their products reached the halls of the White House, where President Joe Biden called for pharma companies to voluntarily bring down the prices for the good of everyone.

Novo Nordisk competitor Eli Lilly responded weeks ago by announcing it would significantly reduce its insulin prices this year.

“For far too long, American families have been crushed by drug costs many times higher than what people in other countries are charged for the same prescriptions. Insulin costs less than $10 to make, but Americans are sometimes forced to pay over $300 for it. It’s flat wrong,” said Biden.





  • A human touch can keep Europe’s elderly in the labor market

    A human touch can keep Europe’s elderly in the labor market

    In many European countries, the older generations are on the verge of retirement. In Northern Europe, companies and organizations are better than elsewhere in Europe at getting seniors to work after retirement age. Some simple tools seem to work

  • Copenhagen ranked 4th for career growth

    Copenhagen ranked 4th for career growth

    Copenhagen is ranked as the fourth-best city in the world for career growth, according to an analysis by EnjoyTravel. This ranking considers various factors such as living costs, salary levels, workforce availability, and overall quality of life. Copenhagen is noted for its blend of historical and modern elements, particularly in the green energy sector, which influences job opportunities.

  • Data shows that non-Western immigrants have saved local economies in Denmark

    Data shows that non-Western immigrants have saved local economies in Denmark

    A study reveals how only the massive influx of non-Western immigrants has saved many areas in Denmark from a decline in the workforce and a consequently shrinking economy